Bridging medicine and technology: FDA approves first di...
August 1, 2019 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 As modern technology continues to grow ever more complex and powerful, it is no surprise that the healthcare industry is constantly searching for medical applications of the latest technological advancements. Whether it be new health system software or medical devices for at home testing, the integration of… |
|
Epilepsy, children, and how the pharmacist can play a v...
August 1, 2019 - Featured , Professional Advice / Opinions By: Evanthia Siozios, PharmD Candidate c/o 2020 A diagnosis of epilepsy requires either two unprovoked seizures or one unprovoked seizure with the possibility of having more.1 These seizures are not usually caused by factors such as alcohol withdrawal or hypoglycemia (low blood sugar). Missing doses of seizure medication is the most common cause of… |
|
The “Netflix” approach to hepatitis C drugs...
August 1, 2019 - Featured , In the News / Politics By: Michael Lim, PharmD Candidate c/o 2020 In a February 2019 Senate Finance Committee hearing, executives from major pharmaceutical companies including AbbVie, Merck, and AstraZeneca were criticized for the high cost of brand-name prescription drugs.1 When asked why brand-name prescription drugs in the United States were more expensive compared to other developed countries, an… |